Americans can choose a Covid-19 booster shot that is different from their original inoculation but the recommendation is to stick with the vaccine they got first if available, White House chief medical adviser Dr. Anthony Fauci said on Oct. 22.
If you are not happy with the results below please do another search
50 search results for:
The Pfizer/BioNTech Covid-19 vaccine showed 90.7 percent efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Oct. 22.
This Whitepaper discusses the different approaches to real-time qPCR, outlines considerations to help quickly compare previously optimized qPCR assays with a new qPCR Master Mix, offers guidance for optimizing your real-time qPCR assay and provides a tool for comparing qPCR reagent formulations.
Pfizer, Moderna, and AstraZeneca have been running “dress rehearsals” by adapting their current formulations of Covid-19 vaccines to match present known SARS-CoV-2 variants.
OpGen Subsidiary Ares Genetics Launches AREScloud AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolates AREScloud offers an advanced solution for infection prevention and control ROCKVILLE, Md., Oct. 21, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power […]
Nearly four months after Intellia Therapeutics – along with partner Regeneron Pharmaceuticals – reinvigorated the CRISPR space with the first-ever clinical evidence that CRISPR gene editing inside the body can be safe and effective, the asset in question was granted Orphan Drug Designation by the U.S. Food and Drug Administration.
tec5USA, a leading designer and manufacturer of in-line process spectrometers, announced plans to host a free webinar on November 10th discussing the growing problem of counterfeit medications and their handheld solution for detection.
Med Ad News spoke with Jon Koch, the new CEO of Fishawack Health. Koch discussed his background, why he joined Fishawack Health, and what differentiates the company from others in the healthcare communications space.
A trial assessing an experimental AstraZeneca cancer drug was placed on clinical hold due to safety concerns. The trial pause comes two years after Amgen was also forced to pause a study of a drug within the same class.
F-star Therapeutics announced a new partnership with Janssen Biotech on Oct. 20, only one month after presenting an optimistic trial-in-progress update to the public on the clinical-stage biopharma company’s tetravalent dual T-cell agonist FS120 at the European Society for Medical Oncology 2021 Conference.